NewCardio, Inc. (NWCI)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 1, 2025
NewCardio Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
NewCardio has 40.81 million shares outstanding.
| Current Share Class | 40.81M |
| Shares Outstanding | 40.81M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.07% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.61 |
| Interest Coverage | -17.74 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -224.19% |
| Return on Invested Capital (ROIC) | -2,959.09% |
| Return on Capital Employed (ROCE) | 141.94% |
| Revenue Per Employee | 23,858 |
| Profits Per Employee | -883,975 |
| Employee Count | 10 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -151.28 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 46.48 |
| Average Volume (20 Days) | 15,600 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.45 |
Income Statement
In the last 12 months, NewCardio had revenue of 238,582 and -8.84 million in losses. Loss per share was -0.28.
| Revenue | 238,582 |
| Gross Profit | 70,812 |
| Operating Income | -7.34M |
| Pretax Income | -8.84M |
| Net Income | -8.84M |
| EBITDA | -7.26M |
| EBIT | -7.34M |
| Loss Per Share | -0.28 |
Balance Sheet
The company has 13,064 in cash and 4.16 million in debt, giving a net cash position of -4.14 million or -0.10 per share.
| Cash & Cash Equivalents | 13,064 |
| Total Debt | 4.16M |
| Net Cash | -4.14M |
| Net Cash Per Share | -0.10 |
| Equity (Book Value) | -5.53M |
| Book Value Per Share | -0.17 |
| Working Capital | -5.38M |
Cash Flow
In the last 12 months, operating cash flow was -2.57 million and capital expenditures -5,364, giving a free cash flow of -2.58 million.
| Operating Cash Flow | -2.57M |
| Capital Expenditures | -5,364 |
| Free Cash Flow | -2.58M |
| FCF Per Share | -0.06 |
Margins
| Gross Margin | 29.68% |
| Operating Margin | -3,076.73% |
| Pretax Margin | -3,705.12% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NewCardio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.92% |
| Shareholder Yield | -15.92% |
| Earnings Yield | -21,560,370.73% |
| FCF Yield | -6,288,607.32% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NewCardio has an Altman Z-Score of -404.75. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -404.75 |
| Piotroski F-Score | n/a |